Abstract:Introduction Bone marrow mesenchymal stem cells (BMSCs), which have the ability to self-renew and to differentiate into multiple cell types, have recently become a novel strategy for cell-based therapies. The differentiation of BMSCs into keratinocytes may be beneficial for patients with burns, disease, or trauma. However, the currently available cells are exposed to animal materials during their cultivation and induction. These xeno-contaminations severely limit their clinical outcomes. Previous studies have shown that the Rho kinase (ROCK) inhibitor Y-27632 can promote induction efficiency and regulate the self-renewal and differentiation of stem cells. In the present study, we attempted to establish a xeno-free system for the differentiation of BMSCs into keratinocytes and to investigate whether Y-27632 can facilitate this differentiation. Methods BMSCs isolated from patients were cultured by using a xeno-free system and characterised by using flow cytometric analysis and adipogenic and osteogenic differentiation assays. Human primary keratinocytes were also isolated from patients. Then, the morphology, population doubling time, and β-galactosidase staining level of these cells were evaluated in the presence or absence of Y-27632 to determine the effects of Y-27632 on the state of the keratinocytes. Keratinocyte-like cells (KLCs) were detected at different time points by immunocytofluorescence analysis. Moreover, the efficiency of BMSC differentiation under different conditions was measured by quantitative real-time-polymerase chain reaction (RT-PCR) and Western blot analyses. Results The ROCK inhibitor Y-27632 promoted the proliferation and lifespan of human primary keratinocytes. In addition, we showed that keratinocyte-specific markers could be detected in BMSCs cultured in a xeno-free system using keratinocyte-conditioned medium (KCM) independent of the presence of Y-27632. However, the efficiency of the differentiation of BMSCs into KLCs was significantly higher in the presence of Y-27632 using immunofluorescence, quantitative RT-PCR, and Western blot analyses. Conclusions This study demonstrated that Y-27632 could promote the proliferation and survival of human primary keratinocytes in a xeno-free culture system. In addition, we found that BMSCs have the ability to differentiate into KLCs in KCM and that Y-27632 can facilitate this differentiation. Our results suggest that BMSCs are capable of differentiating into KLCs in vitro and that the ROCK pathway may play a critical role in this process.

Influence of Rho/ROCK inhibitor Y-27632 on proliferation of equine mesenchymal stromal cells

Rho-associated Kinase Inhibitor, Y-27632, Inhibits the Invasion and Proliferation of T24 and 5367 Bladder Cancer Cells

The Rho kinase inhibitor Y-27632 facilitates the differentiation of bone marrow mesenchymal stem cells

Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells

Rho-Associated Kinase Inhibitor (Y-27632) Attenuates Doxorubicin-Induced Apoptosis of Human Cardiac Stem Cells

Rho‐kinase Inhibitor Y‐27632 Facilitates the Proliferation, Migration and Pluripotency of Human Periodontal Ligament Stem Cells

The Stimulatory Effect of ROCK Inhibitor on Bovine Corneal Endothelial Cells

Pre-conditioning of Equine Bone Marrow-Derived Mesenchymal Stromal Cells Increases Their Immunomodulatory Capacity

Epithelial–mesenchymal transition of rat peritoneal mesothelial cells via Rhoa/Rock pathway

Rho Kinase Inhibitor Y-27632 Promotes the Differentiation of Human Bone Marrow Mesenchymal Stem Cells into Keratinocyte-Like Cells in Xeno-Free Conditioned Medium

Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs

RhoA/Rho Kinase Signaling Regulates Transforming Growth Factor-Β1-induced Chondrogenesis and Actin Organization of Synovium-Derived Mesenchymal Stem Cells Through Interaction with the Smad Pathway

Transforming Growth Factor Β1-Induced Epithellal-Mesenchymal Transition of Rat Peritoneal Mesothelial Cells Via RhoA-Rock Signaling Pathway

Comparing the immunomodulatory properties of equine BM-MSCs culture expanded in autologous platelet lysate, pooled platelet lysate, equine serum and fetal bovine serum supplemented culture media

A novel direct co-culture assay analyzed by multicolor flow cytometry reveals context- and cell type-specific immunomodulatory effects of equine mesenchymal stromal cells

Inhibition Of Rhoa/Rho-Kinase Pathway Suppresses The Expression Of Extracellular Matrix Induced By Ctgf Or Tgf-Beta In Arpe-19

Bone Marrow MSC Secretome Increases Equine Articular Chondrocyte Collagen Accumulation and Their Migratory Capacities

ROCK inhibitor enhances the growth and migration of BRAF mutant skin melanoma cells.

Equine Mesenchymal Stem Cells Influence the Proliferative Response of Lymphocytes: Effect of Inflammation, Differentiation and MHC-Compatibility

Y-27632 enables long-term expansion of mouse submandibular gland epithelial cells via inactivation of TGF-β1/CTGF/p38 and ROCK2/JNK signaling pathway

Effects of inhibition of rhodopsin kinase of 4-aminopyridines compounds on epithelial-mesenchymal transition of rat peritoneal mesothelial cells